Follow the Getinge AB share price and the full directors' dealings record of the company, a listed issuer based in Finland. Shares are listed on FI FI, under the supervision of FIN-FSA. Operating in the Health Care sector, Getinge AB has recorded 2 reports. Market capitalisation: €52.3bn. The latest transaction was reported on 25 April 2026 (Purchase). Among the most active insiders: Carl Bennet. The full history is accessible without an account.
Analysts rate Getinge AB Buy (bullish), based on 10 analysts. Average price target: SEK 224.70.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
2 of 2 declarations